EUVIMEDEUVIMED entdecken
Crossref

Docetaxel‐Encapsulated Catalytic Pt/Au Nanotubes for Synergistic Chemo‐Photothermal Therapy of Triple‐Negative Breast Cancer

Haiyan Yang, Qian Zhang, Liwei Dai, Yazi Wang, Guangrong Zheng, Xinyue Zhang, Di Zheng, Xiaojuan Ji, Yutao Sang iD, Zhihong Nie iD

Advanced Healthcare Materials · 2024-11 · 13 (29)

DOI: 10.1002/adhm.202400662 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 27.08.2024. Verfasst von Haiyan Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Chongqing General Hospital, Chongqing University, Chongqing, 401147, P. R. China. Hauptthemen laut MEDLINE: Docetaxel, Triple Negative Breast Neoplasms, Gold, Nanotubes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Innovation Program of Shanghai Municipal Education Commission, National Key R & D Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The combination of photothermal therapy with chemotherapy has emerged as a promising therapeutic modality for addressing triple‐negative breast cancer (TNBC). This manuscript describes a novel hybrid nanoplatform comprising ultrathin catalytic platinum/gold (Pt/Au) nanotubes encapsulated with docetaxel and phase‐change materials (PCMs) for the photoacoustic imaging‐guided synergistic chemo‐photothermal therapy of TNBC. Upon irradiation of near‐infrared laser, the photothermal heating of nanotubes converts solid‐state PCM into liquid, triggering the controlled release of the encapsulated docetaxel. The thin Pt layer within nanotubes enhances the nanotube's thermal stability, thus prolonging the photothermal ablation of tumors. Furthermore, platinum effectively mitigates tumor hypoxia by catalyzing the decomposition of hydrogen peroxides to generate oxygen in the tumor microenvironment, thus improving the efficiency of chemotherapy. It is demonstrated that the drug‐loaded nanotubes achieve significant tumor inhibition rates of 75.4% in vivo on 4T1 tumor‐bearing mice, significantly surpassing control groups. These nanotubes also notably extend survival, attributable to the synergistic effects of prolonged photothermal therapy facilitated by platinum and oxygenation‐enhanced chemotherapy. This combination leverages the unique properties of the Pt/Au NTs‐DTX/PCM nanoplatform, optimizing therapeutic outcomes. It is envisioned that this nanoplatform may find important applications in managing superficial malignant solid tumors in general.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DocetaxelTriple Negative Breast NeoplasmsGoldNanotubesPlatinumPhotothermal TherapyAnimalsMiceFemaleCell Line, TumorMice, Inbred BALB CAntineoplastic AgentsHumansCatalysis

Stichwörter der Autor:innen

breast cancerchemotherapydocetaxelnanotubesphotothermal therapy

Substanzen

DocetaxelGoldPlatinumAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Ultrasound, Chongqing General Hospital, Chongqing University, Chongqing, 401147, P. R. China.
  • State Key Laboratory of Molecular Engineering of Polymers, Department of Macromolecule Science, Fudan University, Shanghai, 200438, P. R. China.
  • State Key Laboratory of Ultrasound in Medicine and Engineering, Chongqing Medical University, Chongqing, 400146, P. R. China.
  • Department of Materials Science and Engineering, University of Maryland, College Park, 20742, USA.
  • Department of Radiology, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, 650051, P. R. China.
  • Department of ultrasound, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, C…

ORCID-Profile: Yutao Sang, Zhihong Nie

Förderung

  • National Natural Science Foundation of China
  • Innovation Program of Shanghai Municipal Education Commission
  • National Key R & D Program of China
  • Shanghai Pujiang Program
  • China Postdoctoral Science Foundation

Zitieren

APA

Yang, H., Zhang, Q., Dai, L., Wang, Y., Zheng, G., Zhang, X., Zheng, D., Ji, X., Sang, Y., & Nie, Z. (2024). Docetaxel‐Encapsulated Catalytic Pt/Au Nanotubes for Synergistic Chemo‐Photothermal Therapy of Triple‐Negative Breast Cancer. Advanced Healthcare Materials, 13(29). https://doi.org/10.1002/adhm.202400662

Vancouver

Yang H, Zhang Q, Dai L, Wang Y, Zheng G, Zhang X, et al. Docetaxel‐Encapsulated Catalytic Pt/Au Nanotubes for Synergistic Chemo‐Photothermal Therapy of Triple‐Negative Breast Cancer. Advanced Healthcare Materials. 2024;13(29). doi:10.1002/adhm.202400662

BibTeX
@article{Yang2024,
  author = {Yang, Haiyan and Zhang, Qian and Dai, Liwei and Wang, Yazi and Zheng, Guangrong and Zhang, Xinyue and Zheng, Di and Ji, Xiaojuan and Sang, Yutao and Nie, Zhihong},
  title = {Docetaxel‐Encapsulated Catalytic Pt/Au Nanotubes for Synergistic Chemo‐Photothermal Therapy of Triple‐Negative Breast Cancer},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {29},
  doi = {10.1002/adhm.202400662}
}
Kostenlos starten →